Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Jan 11;183(1):26-7.
doi: 10.1503/cmaj.101842.

Off-label use of recombinant factor VIIa: why we need better drug monitoring

Affiliations
Comment

Off-label use of recombinant factor VIIa: why we need better drug monitoring

Paul C Hébert et al. CMAJ. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Lin Y, Stanworth S, Birchall J, et al. Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis. CMAJ 2011:183;E9–19 - PMC - PubMed
    1. Levi M, Levy JH, Andersen HF, et al. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010;363:1791–800 - PubMed
    1. European Medicines Agency NovoSeven. London (UK): The Agency; 2010. Available: www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000... (accessed 2010 Dec. 10).
    1. Kenet G, Walden R, Eldad A, et al. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999;354:1879. - PubMed
    1. The Haemostasis Registry — How far have we come and what do we have to show for it? Victoria (Australia): Monash University; 2008. Available:www.med.monash.edu.au/epidemiology/traumaepi/workshop09.html (accessed 2010 Dec. 10).